Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Klotho Neurosciences, Inc. (KLTO) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.09M |
|
-- |
|
-- |
|
$1.89M |
|
$-1.89M |
|
$-2.20M |
|
$-4.09M |
|
$-4.09M |
|
$-4.09M |
|
$-4.09M |
|
$-4.09M |
|
$-4.09M |
|
$-1.89M |
|
$-1.89M |
|
33.95M |
|
33.95M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$8.55M |
|
-- |
|
$2.30M |
|
$10.85M |
|
$0.06M |
|
-- |
|
$0.13M |
|
$0.20M |
|
$10.65M |
|
$8.35M |
|
$10.65M |
|
52.70M |
|
| Cash Flow Statement Financials | |
$-3.52M |
|
-- |
|
$11.89M |
|
$0.06M |
|
$8.43M |
|
$8.37M |
|
$0.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
135.74 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.43% |
|
-49.02% |
|
-37.74% |
|
-38.43% |
|
$0.20 |
|
$-0.10 |
|
$-0.10 |
|